Oncogenic osteomalacia: Culprit tumour detection whole body magnetic resonance imaging

Internal Medicine Journal

Volumn 33, Issue 12, 2003, Pages 615-616

  Dissanayake, A M ^a   Wilson, J L ^b   Holdaway, I M ^b   Reid, I R ^c  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PHOSPHATE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BONE BIOPSY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; MALE; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; PRIORITY JOURNAL; STRESS FRACTURE; TREATMENT OUTCOME;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HEMANGIOPERICYTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMOMA; MIDDLE AGED; OSTEOMALACIA; SPINAL CANAL;

EID: 1642430603     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2003.00488.x     Document Type: Article

References (4)

1. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S et al. Cloning and characterization of FGF-23 as a causative factor of tumour-induced osteomalacia. Proc Natl Acad Sci USA 2001; 11: 6500-5.
2. Nelson AE, Mason RS, Robinson BG, Hogan JJ, Martin EA, Ahlstrom H et al. Diagnosis of a patient with oncogenic osteomalacia using a phosphate uptake bioassay of serum and magnetic resonance imaging. Eur J Endocrinol 2001; 145: 469-76.
3. Fukumoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 1999; 25: 375-7.
4. Avila NA, Skarulis M, Rubino DM, Doppman JL. Oncogenic osteomalacia: lesion detection by MR skeletal survey. Am J Roentgenol 1996; 167: 343-5.